A clinical trial using engineered immune cells to hunt cancer cells has reported impressive results for solid tumours, a type ...

Karla Flores was diagnosed with a rare brain tumor. An misplaced MRI found a second, nearly inoperable, tumor on her spine.

The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was ...

Today some of the most aggressive solid tumor cancers remain stubbornly resistant to treatment. There are many reasons why ...

START and OneOncology launch 3 new early-phase trial sites, expanding access to new cancer research in community oncology ...

A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

Merck KGaA has shown off data that fueled its $85 million bet on a late-phase treatment for a rare, locally aggressive tumor.

Clinical and molecular determinants of survival in pancreatic neuroendocrine tumors: A comprehensive analysis from SEER and TCGA databases.

Genomic characterization of STAS in stage 1 EGFR-mutated NSCLC and prognostic implications.

For nearly 50 years, McLeod has been accredited by the Commission on Cancer of the American College of Surgeons. Photo ...